These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6749590)

  • 1. Macrophage activities in sarcoma 180-bearing mice and EL4-bearing mice.
    Kurashige S; Mitsuhashi S
    Gan; 1982 Feb; 73(1):85-90. PubMed ID: 6749590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depression of resistance against Salmonella infection in sarcoma 180-bearing mice and its restoration by Salmonella mini-cells.
    Kurashige S; Akuzawa Y
    Jpn J Exp Med; 1984 Jun; 54(3):91-6. PubMed ID: 6394849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Studies on the possible causes of decreasing NK cell activity in tumor-bearing mice. I. The number of NK cells in the spleens of tumor-bearing mice is higher than that in normal mice].
    Fu JY
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1989 Dec; 11(6):421-4. PubMed ID: 2534577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Studies on the possible causes of decreasing NK cell activity in tumor-bearing mice. II. Serum and peritoneal exudate from ascitic tumor-bearing mice suppress NK cell activity].
    Fu JY
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1989 Dec; 11(6):446-8. PubMed ID: 2534583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Actions of lectins from the mushroom Tricholoma mongolicum on macrophages, splenocytes and life-span in sarcoma-bearing mice.
    Wang HX; Ng TB; Ooi VE; Liu WK; Chang ST
    Anticancer Res; 1997; 17(1A):419-24. PubMed ID: 9066687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoregulatory circuit among macrophage subsets for T cell-mediated cytotoxic response to tumor cells.
    Ting CC; Rodrigues D
    J Immunol; 1980 Mar; 124(3):1039-44. PubMed ID: 6444645
    [No Abstract]   [Full Text] [Related]  

  • 7. Modulation of immune effector cell cytolytic activity and tumour growth inhibition in vivo by Ukrain (NSC 631570).
    Liepins A; Nowicky JW
    Drugs Exp Clin Res; 1996; 22(3-5):103-13. PubMed ID: 8899312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune response of BALB/c X DBA/2F1 mice to a tumor allograft during pyran copolymer-induced tumor enhancement.
    Schultz RM; Woods WA; Mohr SJ; Chirigos MA
    Cancer Res; 1976 May; 36(5):1641-6. PubMed ID: 1268825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of blockage of macrophage on tumor-suppressive activity of polyactin B.
    Xu C; Wang X; Wang B; Han S; Zhang Y; Si L
    Chin Med J (Engl); 1998 Sep; 111(9):861-3. PubMed ID: 11155684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of lymphokine production by macrophages infiltrating murine virus-induced tumors.
    Varesio L; Herberman RB; Gerson JM; Holden HT
    Int J Cancer; 1979 Jul; 24(1):97-102. PubMed ID: 314424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic anti-suppressor effect of mini cells prepared from Salmonella typhimurium and mitomycin C in EL 4-bearing mice.
    Kurashige S; Akuzawa Y; Mitsuhashi S
    Cancer Immunol Immunother; 1985; 19(2):127-9. PubMed ID: 3157437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancing effects of mini-cells prepared from Salmonella typhimurium on anti-tumor immunity in sarcoma 180-bearing mice.
    Kurashige S; Mitsuhashi S
    Cancer Immunol Immunother; 1982; 14(1):1-3. PubMed ID: 6760962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of PSK on the recovery of macrophage function in tumor-bearing mice].
    Ando T; Mastuda Y; Matsunaga K; Fujii T; Yoshikumi C; Nomoto K
    Gan To Kagaku Ryoho; 1984 Apr; 11(4):827-34. PubMed ID: 6721504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ia-bearing macrophages in athymic mice: antigen presentation and regulation.
    Lu CY; Peters E; Unanue ER
    J Immunol; 1981 Jun; 126(6):2496-8. PubMed ID: 6939753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement of macrophage dysfunction by administration of anti-transforming growth factor-beta antibody in EL4-bearing hosts.
    Maeda H; Tsuru S; Shiraishi A
    Jpn J Cancer Res; 1994 Nov; 85(11):1137-43. PubMed ID: 7829399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Humoral mechanisms of the membrano-toxic effects of mastocytoma P815 and leukemia EL4 cells].
    Medvedev AE; Fuks BB
    Biull Eksp Biol Med; 1989 Aug; 108(8):194-6. PubMed ID: 2508789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased susceptibility to tumor cell immunosuppressive effect in tumor-bearing mice.
    Ting CC; Rodrigues D
    J Natl Cancer Inst; 1980 Jul; 65(1):205-9. PubMed ID: 6967124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of macrophage chemotaxins in tumor cell cultures and comparison with lymphocyte-derived chemotactic factors.
    Meltzer MS; Stevenson MM; Leonard EJ
    Cancer Res; 1977 Mar; 37(3):721-5. PubMed ID: 837372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody-mediated suppression of grafted lymphoma. III. Evaluation of the role of thymic function, non-thymus-derived lymphocytes, macrophages, platelets, and polymorphonuclear leukocytes in syngeneic and allogeneic hosts.
    Shin HS; Hayden M; Langley S; Kaliss N; Smith MR
    J Immunol; 1975 Apr; 114(4):1255-63. PubMed ID: 1078832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T cell recognition of Moloney sarcoma virus proteins during tumor regression. I. Lack of a requirement for macrophages and the role of blastogenic factors in T cell proliferation.
    Enjuanes L; Lee JC; Ihle JN
    J Immunol; 1981 Apr; 126(4):1478-84. PubMed ID: 6970777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.